Partager
Back

HUMAN
VACCINES

Focus

Fluzone®, a vaccine for universal coverage

Since 2010, the United States recommends universal vaccination for seasonal flu. To respond to this demand, Sanofi Pasteur has developed the innovative Fluzone® family of vaccines specifically for this market. The family comprises three vaccines: Fluzone®, a classic intramuscular injection; Fluzone® High-Dose, specifically developed for people 65 and over; and Fluzone® ID, administered intradermally with a very fine needle. The Fluzone® family thus increases administration comfort and the rate of vaccinal coverage for influenza in adults.

Read more